Purification of Pharmaceutical and Biotechnology Products with Kromasil EternityXT Stationary Phase

Chromatography

Purification of Pharmaceutical and Biotechnology Products with Kromasil EternityXT Stationary Phase

29 Mar, 2017

Published over 9 years ago. See the latest and most current information on Chromatography.

With excellent mechanical and chemical stability, the Kromasil EternityXT materials offer first-rate separation power and loadability for purification from low to high pH. Kromasil EternityXT C8 and C18 materials can operate up to pH 12, making it possible to run basic compounds under extreme conditions to improve purification productivity and reduce costs. These products support discovery, development and production departmental goals in the purification of a low molecular weight pharmaceuticals, peptides and biotechnology products.

The exceptional structure of Kromasil EternityXT C18 and C8 materials makes it possible to regenerate the material in-column, carrying out cleaning in place (CIP) even at 1 M NaOH, if so required. While this high concentration NaOH treatment is a standard in bio chromatography and until now only conceivable with polymer resins, Kromasil EternityXT materials open up the spectrum of purification options as its C8 and C18 materials resist up to 1 M NaOH.

Latest News

ILM Guide 2026/27

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
AI to stop 165 million litres of water waste
Explore more Arrow
Pollution Solutions Online
AI-driven in-line inspection improves leak and air pocket detection in water networks
Explore more Arrow
Petro Online
ABB enables thermal mass flow measurement in safety-critical applications with SIL 2 certification
Explore more Arrow
Chromatography Today
Affordable liquid chromatography solvent delivery pump
Explore more Arrow